Takeda Pharmaceutical (TAK) Return on Sales [ROS] (2017 - 2026)
Takeda Pharmaceutical (TAK) reported Return on Sales [ROS] of 16.51% for the quarter ended Jun 30, 2026, down 0.17 percentage points from 16.68% a year earlier and unchanged from the prior quarter.
Takeda Pharmaceutical (TAK) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's Return on Sales [ROS] came in at 5.83%, down 4.55 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 0.14%, down 7.34 percentage points from the prior year.
- Return on Sales [ROS] has a five-year change of -15.79 percentage points (years ended Mar 2021 to Mar 2026).
- By year, Return on Sales [ROS] came in at 7.48% in the year ended Mar 31, 2025 (+2.46 pp), 5.02% in the year ended Mar 31, 2024 (-7.16 pp), 12.18% in the year ended Mar 31, 2023 (-0.73 pp) and 12.91% in the year ended Mar 31, 2022 (-3.01 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of -38.03% in the quarter ended Dec 31, 2025 and a high of 25.56% in the quarter ended Mar 31, 2022.
- Year over year, Return on Sales [ROS] gained in four of the last eight quarters, with an average year-over-year change of -5.21 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was the quarter ended Jun 30, 2025 (a gain of 2.91 percentage points); the low point was the quarter ended Dec 31, 2025 (a drop of 30.92 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 16.51% (quarter ended Mar 31, 2026), -38.03% (quarter ended Dec 31, 2025) and 11.97% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | 16.51% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.51% |
| Mar 31, 2026 | 16.51% |
| Dec 31, 2025 | -38.03% |
| Sep 30, 2025 | 11.97% |
| Jun 30, 2025 | 16.68% |
| Mar 31, 2025 | 15.28% |
| Dec 31, 2024 | -7.11% |
| Sep 30, 2024 | 11.83% |
| Jun 30, 2024 | 13.77% |
| Mar 31, 2024 | 13.96% |
| Dec 31, 2023 | 8.43% |
| Sep 30, 2023 | 12.51% |
| Jun 30, 2023 | 15.92% |
| Mar 31, 2023 | 15.93% |
| Dec 31, 2022 | 13.40% |
| Sep 30, 2022 | 10.42% |
| Jun 30, 2022 | 15.48% |
| Mar 31, 2022 | 25.56% |
| Jun 30, 2021 | 26.17% |
| Mar 31, 2021 | 32.27% |
Takeda Pharmaceutical Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();